Cite Filings / VRDN / 0001193125-21-279564
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

Viridian Therapeutics, Inc.DE · Filed 2021-09-22 · Acc 0001193125-21-279564

Documents 1

  • 424B5 Prospectus , d234004d424b5.htm

Around this filing

  • 2022-08-15 424B5 Prospectus
  • 2021-09-24 SC 13G Amended Statement of Ownership
  • 2021-09-23 SC 13D/A Beneficial Ownership Report
  • 2021-09-23 8-K Material agreement · Bylaws or fiscal year change
  • 2021-09-23 4 Director bought 909,000 shares at $11.00 ($9,999,000)
  • 2021-09-22 424B5 Prospectus
  • 2021-09-20 424B5 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d234004d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…